{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:27:45Z","timestamp":1786577265694,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100032917","name":"Navamindradhiraj University","doi-asserted-by":"crossref","award":["79\/2564"],"award-info":[{"award-number":["79\/2564"]}],"id":[{"id":"10.13039\/100032917","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54798-1","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:15:57Z","timestamp":1780413357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of morning or evening antihypertensive drug administration on albuminuria in hypertensive patients: an open-label pilot randomized controlled trial"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8788-0730","authenticated-orcid":false,"given":"Thanphisit","family":"Trakarnvanich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1100-7171","authenticated-orcid":false,"given":"Surapon","family":"Nochaiwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7927-1425","authenticated-orcid":false,"given":"Chidchanok","family":"Ruengorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0335-3069","authenticated-orcid":false,"given":"Kiatkriangkrai","family":"Koyratkoson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0119-4647","authenticated-orcid":false,"given":"Tanun","family":"Ngamvichchukorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"Suppl 1","key":"54798_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.hjh.0000410246.59221.b1","volume":"29","author":"H Arima","year":"2011","unstructured":"Arima, H., Barzi, F. & Chalmers, J. Mortality patterns in hypertension. J. Hypertens. 29(Suppl 1), S3-7 (2011).","journal-title":"J. Hypertens."},{"issue":"7868","key":"54798_CR2","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/S0140-6736(74)91002-2","volume":"1","author":"HH Parving","year":"1974","unstructured":"Parving, H. H., Mogensen, C. E., Jensen, H. A. & Evrin, P. E. Increased urinary albumin-excretion rate in benign essential hypertension. Lancet 1(7868), 1190\u20132 (1974).","journal-title":"Lancet"},{"issue":"1","key":"54798_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/jch.12660","volume":"18","author":"A Mani","year":"2016","unstructured":"Mani, A. Albuminuria in Hypertensive Patients: Where the Choice of Antihypertensive Medications Matters:: Commentary on Several Conventional Risk Markers Suggesting Presence of Albuminuria Are Weak Among Rural Africans With Hypertension. J. Clin. Hypertens. (Greenwich). 18 (1), 31\u201332 (2016).","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"Suppl 1","key":"54798_CR4","first-page":"S40","volume":"38","author":"M Rambausek","year":"1992","unstructured":"Rambausek, M., Fliser, D. & Ritz, E. Albuminuria of hypertensive patients. Clin. Nephrol. 38(Suppl 1), S40-5 (1992).","journal-title":"Clin. Nephrol."},{"issue":"3","key":"54798_CR5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/cs0380359","volume":"38","author":"J Lowenstein","year":"1970","unstructured":"Lowenstein, J., Beranbaum, E. R., Chasis, H. & Baldwin, D. S. Intrarenal pressure and exaggerated natriuresis in essential hypertension. Clin. Sci. (Lond.) 38(3), 359\u201374 (1970).","journal-title":"Clin. Sci. (Lond.)"},{"issue":"10","key":"54798_CR6","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1371\/journal.pmed.0050207","volume":"5","author":"V Perkovic","year":"2008","unstructured":"Perkovic, V. et al. The relationship between proteinuria and coronary risk: a systematic review and meta-analysis. PLoS Med. 5 (10), e207 (2008).","journal-title":"PLoS Med."},{"issue":"2","key":"54798_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S2213-8587(18)30313-9","volume":"7","author":"J Coresh","year":"2019","unstructured":"Coresh, J. et al. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. Lancet Diabetes Endocrinol. 7 (2), 115\u2013127 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"54798_CR8","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1161\/HYPERTENSIONAHA.110.165563","volume":"57","author":"A Oliveras","year":"2011","unstructured":"Oliveras, A., Armario, P., Martell-Clar\u00f3s, N., Ruilope, L. M. & de la Sierra, A. Urinary albumin excretion is associated with nocturnal systolic blood pressure in resistant hypertensives. Hypertension 57 (3), 556\u2013560 (2011).","journal-title":"Hypertension"},{"issue":"10","key":"54798_CR9","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.2337\/dc16-0748","volume":"39","author":"G Ruiz-Hurtado","year":"2016","unstructured":"Ruiz-Hurtado, G. et al. Association Between High and Very High Albuminuria and Nighttime Blood Pressure: Influence of Diabetes and Chronic Kidney Disease. Diabetes Care. 39 (10), 1729\u20131737 (2016).","journal-title":"Diabetes Care"},{"issue":"4","key":"54798_CR10","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/HYPERTENSIONAHA.112.198101","volume":"60","author":"J Ishikawa","year":"2012","unstructured":"Ishikawa, J. et al. Nighttime home blood pressure and the risk of hypertensive target organ damage. Hypertension 60 (4), 921\u2013928 (2012).","journal-title":"Hypertension"},{"issue":"1\u20132","key":"54798_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3109\/07420528.2012.715843","volume":"30","author":"R Manfredini","year":"2013","unstructured":"Manfredini, R. et al. Twenty-four-hour patterns in occurrence and pathophysiology of acute cardiovascular events and ischemic heart disease. Chronobiol. Int. 30(1\u20132), 6\u201316 (2013).","journal-title":"Chronobiol. Int."},{"issue":"7","key":"54798_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ajem.2004.08.014","volume":"22","author":"R Manfredini","year":"2004","unstructured":"Manfredini, R. et al. Influence of circadian rhythm on mortality after myocardial infarction: data from a prospective cohort of emergency calls. Am. J. Emerg. Med. 22 (7), 555\u2013559 (2004).","journal-title":"Am. J. Emerg. Med."},{"issue":"9","key":"54798_CR13","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/01.CIR.0000027568.39540.4B","volume":"106","author":"RH Mehta","year":"2002","unstructured":"Mehta, R. H. et al. Chronobiological patterns of acute aortic dissection. Circulation 106 (9), 1110\u20131115 (2002).","journal-title":"Circulation"},{"issue":"5","key":"54798_CR14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41371-024-00909-2","volume":"38","author":"PA Lempi\u00e4inen","year":"2024","unstructured":"Lempi\u00e4inen, P. A., Ylitalo, A., Huikuri, H., Kes\u00e4niemi, Y. A. & Ukkola, O. H. Non-dipping blood pressure pattern is associated with cardiovascular events in a 21-year follow-up study. J. Hum. Hypertens. 38(5), 444\u201351 (2024).","journal-title":"J. Hum. Hypertens."},{"issue":"10361","key":"54798_CR15","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(22)01786-X","volume":"400","author":"IS Mackenzie","year":"2022","unstructured":"Mackenzie, I. S. et al. Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): A prospective, randomised, open-label, blinded-endpoint clinical trial. Lancet 400(10361), 1417\u201325 (2022).","journal-title":"Lancet"},{"issue":"23","key":"54798_CR16","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1001\/jama.2025.4390","volume":"333","author":"SR Garrison","year":"2025","unstructured":"Garrison, S. R. et al. Antihypertensive medication timing and cardiovascular events and death: The BedMed Randomized Clinical Trial. JAMA 333(23), 2061\u201372 (2025).","journal-title":"JAMA"},{"issue":"7","key":"54798_CR17","doi-asserted-by":"publisher","first-page":"e2519354","DOI":"10.1001\/jamanetworkopen.2025.19354","volume":"8","author":"R Ye","year":"2025","unstructured":"Ye, R. et al. Morning vs Bedtime Dosing and Nocturnal Blood Pressure Reduction in Patients With Hypertension: The OMAN Randomized Clinical Trial. JAMA Netw. Open. 8 (7), e2519354 (2025).","journal-title":"JAMA Netw. Open."},{"issue":"4","key":"54798_CR18","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s11255-016-1437-2","volume":"49","author":"C Wang","year":"2017","unstructured":"Wang, C. et al. Chronotherapy for hypertension in patients with chronic kidney disease: a systematic review and meta-analysis in non-black patients. Int. Urol. Nephrol. 49 (4), 651\u2013659 (2017).","journal-title":"Int. Urol. Nephrol."},{"issue":"48","key":"54798_CR19","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1093\/eurheartj\/ehz754","volume":"41","author":"RC Hermida","year":"2020","unstructured":"Hermida, R. C. et al. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. Eur. Heart J. 41 (48), 4565\u20134576 (2020).","journal-title":"Eur. Heart J."},{"key":"54798_CR20","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz, K. F., Altman, D. G. & Moher, D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 340, c332 (2010).","journal-title":"BMJ"},{"key":"54798_CR21","doi-asserted-by":"publisher","first-page":"i5239","DOI":"10.1136\/bmj.i5239","volume":"355","author":"SM Eldridge","year":"2016","unstructured":"Eldridge, S. M. et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. BMJ 355, i5239 (2016).","journal-title":"BMJ"},{"issue":"12","key":"54798_CR22","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia, G. et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J. Hypertens. 41 (12), 1874\u20132071 (2023).","journal-title":"J. Hypertens."},{"issue":"3","key":"54798_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/jch.14128","volume":"23","author":"K Kario","year":"2021","unstructured":"Kario, K. et al. Guidance on ambulatory blood pressure monitoring: A statement from the HOPE Asia Network. J. Clin. Hypertens. (Greenwich). 23 (3), 411\u2013421 (2021).","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"7","key":"54798_CR24","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1681\/ASN.2010091001","volume":"22","author":"RE Schmieder","year":"2011","unstructured":"Schmieder, R. E. et al. Changes in albuminuria predict mortality and morbidity in patients with vascular disease. J. Am. Soc. Nephrol. 22 (7), 1353\u20131364 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"6","key":"54798_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/BF00735961","volume":"18","author":"RT Gansevoort","year":"1996","unstructured":"Gansevoort, R. T., de Zeeuw, D. & de Jong, P. E. ACE inhibitors and proteinuria. Pharm. World Sci. 18 (6), 204\u2013210 (1996).","journal-title":"Pharm. World Sci."},{"issue":"8","key":"54798_CR26","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1681\/ASN.2005121288","volume":"17","author":"CD Stehouwer","year":"2006","unstructured":"Stehouwer, C. D. & Smulders, Y. M. Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. J. Am. Soc. Nephrol. 17(8), 2106\u201311 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"54798_CR27","unstructured":"Grimm, R. H. Jr., Svendsen, K. H., Kasiske, B., Keane, W. F. & Wahi, M. M. Proteinuria is a risk factor for mortality over 10 years of follow-up. Kidney Int. Suppl. 63, S10-4 (1997)."},{"issue":"14","key":"54798_CR28","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","volume":"106","author":"HL Hillege","year":"2002","unstructured":"Hillege, H. L. et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106 (14), 1777\u20131782 (2002).","journal-title":"Circulation"},{"issue":"4","key":"54798_CR29","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/01.HYP.0000240332.01877.11","volume":"48","author":"K Asayama","year":"2006","unstructured":"Asayama, K. et al. Prediction of stroke by home morning versus evening blood pressure values: the Ohasama study. Hypertension 48 (4), 737\u2013743 (2006).","journal-title":"Hypertension"},{"issue":"10","key":"54798_CR30","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1161\/01.CIR.0000056521.67546.AA","volume":"107","author":"K Kario","year":"2003","unstructured":"Kario, K. et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: A prospective study. Circulation 107(10), 1401\u20136 (2003).","journal-title":"Circulation"},{"issue":"8","key":"54798_CR31","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3109\/07420528.2010.510230","volume":"27","author":"RC Hermida","year":"2010","unstructured":"Hermida, R. C., Ayala, D. E., Moj\u00f3n, A. & Fern\u00e1ndez, J. R. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 27 (8), 1629\u20131651 (2010).","journal-title":"Chronobiol Int."},{"issue":"6","key":"54798_CR32","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.2337\/dc11-0297","volume":"34","author":"RC Hermida","year":"2011","unstructured":"Hermida, R. C., Ayala, D. E., Moj\u00f3n, A. & Fern\u00e1ndez, J. R. Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care. 34 (6), 1270\u20131276 (2011).","journal-title":"Diabetes Care"},{"issue":"12","key":"54798_CR33","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1681\/ASN.2011040361","volume":"22","author":"RC Hermida","year":"2011","unstructured":"Hermida, R. C., Ayala, D. E., Moj\u00f3n, A. & Fern\u00e1ndez, J. R. Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J. Am. Soc. Nephrol. 22 (12), 2313\u20132321 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1\u20132","key":"54798_CR34","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3109\/07420528.2012.709448","volume":"30","author":"RC Hermida","year":"2013","unstructured":"Hermida, R. C. et al. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiol Int. 30 (1\u20132), 280\u2013314 (2013).","journal-title":"Chronobiol Int."},{"issue":"8","key":"54798_CR35","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/jch.12354","volume":"16","author":"GC Roush","year":"2014","unstructured":"Roush, G. C., Fapohunda, J. & Kostis, J. B. Evening dosing of antihypertensive therapy to reduce cardiovascular events: a third type of evidence based on a systematic review and meta-analysis of randomized trials. J. Clin. Hypertens. (Greenwich). 16 (8), 561\u2013568 (2014).","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"3","key":"54798_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/hr.2012.142","volume":"36","author":"H Mori","year":"2013","unstructured":"Mori, H. et al. Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study. Hypertens. Res. 36 (3), 202\u2013207 (2013).","journal-title":"Hypertens. Res."},{"issue":"1","key":"54798_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/07420520600969277","volume":"24","author":"MH Smolensky","year":"2007","unstructured":"Smolensky, M. H., Hermida, R. C. & Portaluppi, F. Comparison of the efficacy of morning versus evening administration of olmesartan in uncomplicated essential hypertension. Chronobiol. Int. 24(1), 171\u201381 (2007).","journal-title":"Chronobiol. Int."},{"issue":"1","key":"54798_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.ajkd.2019.06.009","volume":"75","author":"AS Levey","year":"2020","unstructured":"Levey, A. S. et al. Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: A scientific workshop sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency. Am. J. Kidney Dis. 75(1), 84\u2013104 (2020).","journal-title":"Am. J. Kidney Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54798-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54798-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54798-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T22:51:50Z","timestamp":1786575110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54798-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54798"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54798-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"27 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Vajira Hospital Ethics Committee, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Thailand (approval number 032\/2564; Date of approval 24\/02\/2021). All participants provided written informed consent before enrollment. The study was conducted in accordance with the Declaration of Helsinki and relevant national regulations.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25164"}}